Company news
Shanghai Shen Lian Biomedical Corporation Class A (SSE:688098) news
Shanghai Shen Lian Biomedical Corporation Class A news releases on 6ix. Latest, Nov 20, 2024: Announcement on Voluntary Disclosure of Obtaining Approval…
Press releases — page 2
Announcement on Voluntary Disclosure of Obtaining Approval of New Veterinary Drugs for Swine Pseudorabies Vaccine, Live (Strain JS-A1)
November 19, 2024
Announcement on Resolution of 11th Meeting of 3rd Board of Supervisors
October 30, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
October 11, 2024
Indicative Announcement on Postponing Term Change and Election of Board of Directors and Board of Supervisors
September 20, 2024
2024 Semi-annual Report
August 29, 2024
Voluntary Disclosure Announcement on Outward Investment and Signing of Strategic Cooperation Agreement
August 9, 2024
Announcement on Implementation of Dividend Distribution for 2023
June 6, 2024
Announcement on Resolutions of 2023 Annual General Meeting
May 17, 2024